Shares of Humana Hit 52-Week High

Zacks

On May 30, 2013, the shares of Humana Inc. (HUM) hit a new 52-week high of $83.40. The momentum was driven by strong first-quarter earnings of this Zacks Rank #2 (Buy) stock, which recorded a 51% positive earnings surprise.

Moreover, Humana’s stock price has been soaring since it reported its first quarter results on May 1, resulting in a 12% gain to date. Further, the company reported positive earnings surprise in all the past four quarters, with an average beat of 21.2%.

Humana reported first-quarter 2013 net operating earnings of $407 million or $2.69 per share. The results substantially surpassed the Zacks Consensus Estimate of $1.78 as well as the year-ago earnings of $248 million or $1.49 per share.

Revenues of Humana for the reported quarter climbed 2.6% year over year to $10.49 billion, surpassing the Zacks Consensus Estimate of $10.25 billion. Revenues from premium increased 1% year over year to $9.87 billion, while services revenues surged 50% to $525 million in the reported quarter.

The strong results also prompted Humana to raise its earnings guidance for 2013 to $8.40–$8.60 per share from $7.60–$7.80. The Zacks Consensus Estimate of $8.66 lies above the range, representing a 23.8% year over year improvement.

Moreover, the valuation of Humana looks attractive. The shares are trading at a discount to its peers both on a price-to-book and on a forward price-to-earnings basis, while the return on equity of 15.9% is higher than the peer group average of 12.5%.The year-to-date return from the stock is 21%, above S&P’s return of 16%.

Other health maintenance organizations worth considering are Molina Healthcare Inc. (MOH) – Zacks Rank #1 (Strong Buy), Aetna Inc. (AET) – Zacks Rank #2 (Buy) and Health Net Inc. (HNT) – Zacks Rank #2 (Buy).

Read the Full Research Report on AET

Read the Full Research Report on HUM

Read the Full Research Report on MOH

Read the Full Research Report on HNT

Zacks Investment Research



More From Zacks.com
View Comments (0)